Tufts Says Weak Outcomes Data, Payor Diffidence on MDx Have Slowed the Growth of Personalized Medicine

The study concluded that a lack of evidence linking diagnostic tests to clinical outcomes has made payors skeptical, hindering the growth of personalized medicine.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.